CME is not offered for viewing of the recording.

Objectives

• Describe the epidemiology of obesity and its intersection with diabetes.
• Understand the role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) for diabetes and weight loss.
• Prescribe effective and necessary lifestyle modifications as an accompaniment to pharmacological therapy.

Presentation Slides Flyer Q&A

Speakers

Keynote Speaker

Benjamin O’Donnell, MD
Assistant Professor
Division of Endocrinology, Diabetes, and Metabolism
Medical Director, Medical Weight Management
The Ohio State University Wexner Medical Center

Moderator

Amy Zack, MD
Case Western Reserve University